<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36362211</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13425</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232113425</ELocationID><Abstract><AbstractText>Translation of cell therapies into clinical practice requires the adoption of robust production protocols in order to optimize and standardize the manufacture and cryopreservation of cells, in compliance with good manufacturing practice regulations. Between 2012 and 2020, we conducted two phase I clinical trials (EudraCT 2009-014484-39, EudraCT 2015-004855-37) on amyotrophic lateral sclerosis secondary progressive multiple sclerosis patients, respectively, treating them with human neural stem cells. Our production process of a hNSC-based medicinal product is the first to use brain tissue samples extracted from fetuses that died in spontaneous abortion or miscarriage. It consists of selection, isolation and expansion of hNSCs and ends with the final pharmaceutical formulation tailored to a specific patient, in compliance with the approved clinical protocol. The cells used in these clinical trials were analyzed in order to confirm their microbiological safety; each batch was also tested to assess identity, potency and safety through morphological and functional assays. Preclinical, clinical and in vitro nonclinical data have proved that our cells are safe and stable, and that the production process can provide a high level of reproducibility of the cultures. Here, we describe the quality control strategy for the characterization of the hNSCs used in the above-mentioned clinical trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Profico</LastName><ForeName>Daniela Celeste</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-5721-0410</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelati</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4828-9849</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dipartimento di Biotecnologie e Bioscienze, Universit&#xe0; Milano Bicocca, 20126 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgaravizzi</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricciolini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Projetti Pensi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muzi</LastName><ForeName>Gianmarco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratorio Cellule Staminali, Cell Factory e Biobanca, AOSP S. Maria, 05100 Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cajola</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento di Biotecnologie e Bioscienze, Universit&#xe0; Milano Bicocca, 20126 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Copetti</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit&#xe0; di Biostatistica, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciusani</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7285-123X</Identifier><AffiliationInfo><Affiliation>Laboratorio Analisi, Instituto Nazionale Neurologico C. Besta, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7669-4457</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; di Ingegneria Tissutale, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelain</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-2624-5853</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; di Ingegneria Tissutale, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vescovi</LastName><ForeName>Angelo Luigi</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Produttiva per Terapie Avanzate, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>"Revert Onlus" association</Agency><Country/></Grant><Grant><GrantID>N/A</GrantID><Agency>"IRCCS Casa Sollievo della Sofferenza" research hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="Y">Neural Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015925" MajorTopicYN="N">Cryopreservation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATMP production</Keyword><Keyword MajorTopicYN="N">GMP</Keyword><Keyword MajorTopicYN="N">neural stem cells</Keyword><Keyword MajorTopicYN="N">quality control</Keyword><Keyword MajorTopicYN="N">standardization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36362211</ArticleId><ArticleId IdType="pmc">PMC9653902</ArticleId><ArticleId IdType="doi">10.3390/ijms232113425</ArticleId><ArticleId IdType="pii">ijms232113425</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pluchino S., Zanotti L., Brini E., Ferrari S., Martino G. Regeneration and repair in multiple sclerosis: The role of cell transplantation. Neurosci. Lett. 2009;456:101&#x2013;106. doi: 10.1016/j.neulet.2008.03.097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2008.03.097</ArticleId><ArticleId IdType="pubmed">19429143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindvall O., Odin P. Clinical application of cell transplantation and neurotrophic factors in CNS disorders. Curr. Opin. Neurobiol. 1994;4:752&#x2013;757. doi: 10.1016/0959-4388(94)90019-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0959-4388(94)90019-1</ArticleId><ArticleId IdType="pubmed">7849532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindvall O. Clinical application of neuronal grafts in Parkinson&#x2019;s disease. J. Neurol. 1994;242:S54&#x2013;S56. doi: 10.1007/BF00939243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00939243</ArticleId><ArticleId IdType="pubmed">7699411</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed C.R., Greene P.E., Breeze R.E., Tsai W.-Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., et al. Transplantation of Embryonic Dopamine Neurons for Severe Parkinson&#x2019;s Disease. N. Engl. J. Med. 2001;344:710&#x2013;719. doi: 10.1056/NEJM200103083441002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200103083441002</ArticleId><ArticleId IdType="pubmed">11236774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez I., Sanchez-Pernaute R., Cooper O., Vi&#xf1;uela A., Ferrari D., Bj&#xf6;rklund L., Dagher A., Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson&#x2019;s disease. Brain. 2005;128:1498&#x2013;1510. doi: 10.1093/brain/awh510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh510</ArticleId><ArticleId IdType="pmc">PMC2610438</ArticleId><ArticleId IdType="pubmed">15872020</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Brown M.B., Glass J.D., Boulis N., Johe K., Hazel T., Cudkowicz M., Atassi N., Borges L., Patil P.G., et al. Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS. Ann. Clin. Transl. Neurol. 2018;5:730&#x2013;740. doi: 10.1002/acn3.567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.567</ArticleId><ArticleId IdType="pmc">PMC5989736</ArticleId><ArticleId IdType="pubmed">29928656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Gelati M., Profico D.C., Sgaravizzi G., Pensi M.P., Muzi G., Ricciolini C., Nodari L.R., Carletti S., Giorgi C., et al. Human neural stem cell transplantation in ALS: Initial results from a phase I trial. J. Transl. Med. 2015;27:13&#x2013;17. doi: 10.1186/s12967-014-0371-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-014-0371-2</ArticleId><ArticleId IdType="pmc">PMC4359401</ArticleId><ArticleId IdType="pubmed">25889343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Gelati M., Profico D.C., Sorar&#xf9; G., Ferrari D., Copetti M., Muzi G., Ricciolini C., Carletti S., Giorgi C., et al. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome. Stem Cells Transl. Med. 2019;8:887&#x2013;897. doi: 10.1002/sctm.18-0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0154</ArticleId><ArticleId IdType="pmc">PMC6708070</ArticleId><ArticleId IdType="pubmed">31104357</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi K.-A., Choi Y., Hong S. Stem cell transplantation for Huntington&#x2019;s diseases. Methods. 2018;133:104&#x2013;112. doi: 10.1016/j.ymeth.2017.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2017.08.017</ArticleId><ArticleId IdType="pubmed">28867501</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis C.M., Nicaise A.M., Peruzzotti-Jametti L., Pluchino S. The neural stem cell secretome and its role in brain repair. Brain Res. 2019;1729:146615. doi: 10.1016/j.brainres.2019.146615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2019.146615</ArticleId><ArticleId IdType="pubmed">31863730</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh S.E., Blurton-Jones M. Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem. Int. 2017;106:94&#x2013;100. doi: 10.1016/j.neuint.2017.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.02.006</ArticleId><ArticleId IdType="pmc">PMC5446923</ArticleId><ArticleId IdType="pubmed">28219641</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds B.A., Weiss S. Generation of Neurons and Astrocytes from Isolated Cells of the Adult Mammalian Central Nervous System. Science. 1992;255:1707&#x2013;1710. doi: 10.1126/science.1553558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1553558</ArticleId><ArticleId IdType="pubmed">1553558</ArticleId></ArticleIdList></Reference><Reference><Citation>Gritti A., Fr&#xf6;lichsthal-Schoeller P., Galli R., Parati E.A., Cova L., Pagano S.F., Bjornson C.R., Vescovi A.L. Epidermal and Fibroblast Growth Factors Behave as Mitogenic Regulators for a Single Multipotent Stem Cell-Like Population from the Subventricular Region of the Adult Mouse Forebrain. J. Neurosci. 1999;19:3287&#x2013;3297. doi: 10.1523/JNEUROSCI.19-09-03287.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-09-03287.1999</ArticleId><ArticleId IdType="pmc">PMC6782245</ArticleId><ArticleId IdType="pubmed">10212288</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds B., Tetzlaff W., Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992;12:4565&#x2013;4574. doi: 10.1523/JNEUROSCI.12-11-04565.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.12-11-04565.1992</ArticleId><ArticleId IdType="pmc">PMC6575989</ArticleId><ArticleId IdType="pubmed">1432110</ArticleId></ArticleIdList></Reference><Reference><Citation>Vescovi A.L., Gritti A., Galli R., Parati E.A. Isolation and Intracerebral Grafting of Nontransformed Multipotential Embryonic Human CNS Stem Cells. J. Neurotrauma. 1999;16:689&#x2013;693. doi: 10.1089/neu.1999.16.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.1999.16.689</ArticleId><ArticleId IdType="pubmed">10511241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelati M., Profico D., Projetti-Pensi M., Muzi G., Sgaravizzi G., Vescovi A.L. Culturing and Expansion of &#x201c;Clinical Grade&#x201d; Precursors Cells from the Fetal Human Central Nervous System. Adv. Struct. Saf. Stud. 2013;1059:65&#x2013;77. doi: 10.1007/978-1-62703-574-3_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-574-3_6</ArticleId><ArticleId IdType="pubmed">23934834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalfa C., Nodari L.R., Vacchi E., Gelati M., Profico D., Boido M., Binda E., De Filippis L., Copetti M., Garlatti V., et al. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. Cell Death Dis. 2019;10:345. doi: 10.1038/s41419-019-1582-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1582-5</ArticleId><ArticleId IdType="pmc">PMC6484011</ArticleId><ArticleId IdType="pubmed">31024007</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>